| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000258929.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.003920554 |
Sensitive |
| ENSG00000258929.2 |
Ponatinib |
Bladder urothelial carcinoma |
0.043171112 |
Resistant |
| ENSG00000258929.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.003179708 |
Sensitive |
